MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: Correlation with NPM1 and FLT3 mutation status

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Faraoni, Isabella ^a,b   Laterza, Serena ^a,b   Ardiri, Davide ^a,b   Ciardi, Claudia ^a,b   Fazi, Francesco ^c   Lo Coco, Francesco ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cytogenetically normal AML; FLT3 ITD; MiR 155; MiR 424; NPM1

Indexed keywords

FLT3 LIGAND; MICRORNA; MICRORNA 155; MICRORNA 17 5P; MICRORNA 223; MICRORNA 424; NUCLEOPHOSMIN; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CASE-CONTROL STUDIES; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICRORNAS; MUTATION; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84861947624     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-26     Document Type: Article

References (20)

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD, European LeukemiaNet, Blood 2010 115 453 474 10.1182/blood-2009-07-235358 19880497
2. Current findings for recurring mutations in acute myeloid leukemia. Takahashi S, J Hematol Oncol 2011 4 36 10.1186/1756-8722-4-36 21917154
3. MicroRNAs: new players in acute myeloid leukaemia. Havelange V, Garzon R, Croce CM, Br J Cancer 2009 101 743 748 10.1038/sj.bjc.6605232 19672257
4. The prognostic and functional role of microRNAs in acute myeloid leukemia. Marcucci G, Mrázek K, Radmacher MD, Garzon R, Bloomfield CD, Blood 2011 117 1121 1129 10.1182/blood-2010-09-191312 21045193
5. MicroRNAs in normal and malignant myelopoiesis. Pelosi E, Labbaye C, Testa U, Leuk Res 2009 33 1584 1593 10.1016/j.leukres.2009.04.039 19482355
6. Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Noguera NI, Ammatuna E, Zangrilli D, Lavorgna S, Divona M, Buccisano F, Amadori S, Mecucci C, Falini B, Lo-Coco F, Leukemia 2005 19 1479 1482 Erratum in: Leukemia. 2007, 21:1134 10.1038/sj.leu.2403846 15973451
7. A novel and universal method for microRNA RT-qPCR data normalization. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, Vandesompele J, Genome Biol 2009 10 64 10.1186/gb-2009-10-6-r64 19531210
8. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J, West C, Ragoussis J, Harris AL, Br J Cancer 2011 104 1168 1177 10.1038/sj.bjc.6606076 21407217
9. MiR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Aqeilan RI, Calin GA, Croce CM, Cell Death Differ 2010 17 215 220 10.1038/cdd.2009.69 19498445
10. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, Marchioni M, Masella B, Guarini A, Fatica A, Peschle C, Bozzoni I, Proc Natl Acad Sci USA 2007 104 19849 19854 10.1073/pnas.0706963104 18056638
11. NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression. Starnes LM, Sorrentino A, Pelosi E, Ballarino M, Morsilli O, Biffoni M, Santoro S, Felli N, Castelli G, De Marchis ML, Mastroberardino G, Gabbianelli M, Fatica A, Bozzoni I, Nervi C, Peschle C, Blood 2009 114 1753 1763 10.1182/blood-2008- 12-196196 19542302
12. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D, J Exp Med 2008 205 585 594 10.1084/jem.20072108 18299402
13. MicroRNAs: emerging key regulators of hematopoiesis. Havelange V, Garzon R, Am J Hematol 2010 85 935 942 10.1002/ajh.21863 20941782
14. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B, Proc Natl Acad Sci USA 2008 105 3945 3950 10.1073/pnas.0800135105 18308931
15. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Cammarata G, Augugliaro L, Salemi D, Agueli C, La Rosa M, Dagnino L, Civiletto G, Messana F, Marfia A, Bica MG, Cascio L, Floridia PM, Mineo AM, Russo M, Fabbiano F, Santoro A, Am J Hematol 2010 85 331 339 20425795
16. Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA-target gene interactions in acute myeloid leukemia. Russ AC, Sander S, Lück SC, Lang KM, Bauer M, Rücker FG, Kestler HA, Schlenk RF, Döhner H, Holzmann K, Döhner K, Bullinger L, Haematologica 2011 96 1783 1791 10.3324/haematol.2011.046888 21880628
17. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Fazi F, Racanicchi S, Zardo G, Starnes LM, Mancini M, Travaglini L, Diverio D, Ammatuna E, Cimino G, Lo-Coco F, Grignani F, Nervi C, Cancer Cell 2007 12 457 466 10.1016/j.ccr.2007.09.020 17996649
18. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F, Croce CM, Brunetti E, Grignani F, Peschle C, Nat Cell Biol 2007 9 775 787 10.1038/ncb1613 17589498
19. Quantitative proteomics identify novel miR-155 target proteins. Lössner C, Meier J, Warnken U, Rogers MA, Lichter P, Pscherer A, Schnölzer M, PLoS One 2011 6 22146 10.1371/journal.pone.0022146 21799781
20. Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications. Takahashi S, J Hematol Oncol 2011 4 13 10.1186/1756-8722-4-13 21453545